Overview
- Peptide (C)DGVLVSTQDSRIKQLE, corresponding to amino acid residues 491 - 506 of human Robo1 (Accession Q9Y6N7). Extracellular, N-term.
- Mouse and rat brain membranes; human SH-SY5Y neuroblastoma, MDA-MB-231 breast adenocarcinoma, and THP-1 monocytic leukemia cell lysates (1:200-1:1000).
- Western blot analysis of mouse brain membranes (lanes 1 and 3) and rat brain membranes (lanes 2 and 4):1, 2. Anti-Robo1 (extracellular) Antibody (#ANR-181), (1:200).
3, 4. Anti-Robo1 (extracellular) Antibody, preincubated with Robo1 (extracellular) Blocking Peptide (#BLP-NR181) (#BLP-NR181).
- Mouse brain sections (1:200).
- Human THP-1 monocytic leukemia cells (2.5 µg).
Roundabout (Robo) receptors are a conserved family of four single pass transmembrane proteins1. All members have multiple immunoglobulin-like domains in the extracellular N-terminal region, three extracellular fibronectin type II domains, and cytoplasmic conserved domains. Robos also undergo preoteolytic processing, important for their signaling process2. They serve as receptors for Slit proteins, where upon activation lead to pleiotropic effects including axonal guidance1, axonal repulsion3,4, and neural migration5.
Slit/Robo signaling mainly prevents axons from migrating to inappropriate locations during the assembly of the nervous system6.
Robos are mainly expressed in the nervous system, but are also detected in vascular endothelial and muscle cells7. In non-neuronal tissues, Slit/Robo proteins are key oncogenes and tumor suppressors in various types of cancers. Robo1 expression is elevated in breast cancer and colorectal cancer, and has an overall oncogenic role1.